Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?

Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?

Argues that an HIV-1 vaccine offers the best long-term hope to control the AIDS pandemic, especially in less-developed countries, and that to ensure its future availability, research efforts need to be increased today, including clinical trials. Initial results of the first efficacy trials will be a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2000-06, Vol.10, p.2061-2066
Hauptverfasser: Esparza, J, Bhamarapravati, N
Format: Artikel
Sprache:eng
Schlagworte:
Development
Human immunodeficiency virus
Vaccines
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2066
container_issue
container_start_page 2061
container_title The Lancet (British edition)
container_volume 10
creator Esparza, J
Bhamarapravati, N
description Argues that an HIV-1 vaccine offers the best long-term hope to control the AIDS pandemic, especially in less-developed countries, and that to ensure its future availability, research efforts need to be increased today, including clinical trials. Initial results of the first efficacy trials will be available in the next 2-3 years, and it is important to start planning how new vaccines should be used if found to be effective. Calls for the development of financial mechanisms as an incentive to industry and to ensure equitable distribution of vaccines in less-developed countries. (Original abstract - amended)
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_57809615</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>57809615</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_578096153</originalsourceid><addsrcrecordid>eNqNjrsOgjAYRjtoIl7e4Z-cICnhpi7GGA3uxpUU-JGa0mJbILy9xPgALudbzpecGXGoH1IvToJ4QZbGvCilYUwjh-SnokCBmlkun2BrhBJ7FKptUFpgsoSqs51GYD3jguVccDuCqiC9PTwfelYUXKI5wFCP7gSUX2p0v-daDcc1mVdMGNz8dkW218v9nHqtVu8Ojc0abqYIwSSqzmRRsqP72I-Cv8UPTkZHBQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>57809615</pqid></control><display><type>article</type><title>Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?</title><source>Business Source Complete</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Esparza, J ; Bhamarapravati, N</creator><creatorcontrib>Esparza, J ; Bhamarapravati, N</creatorcontrib><description>Argues that an HIV-1 vaccine offers the best long-term hope to control the AIDS pandemic, especially in less-developed countries, and that to ensure its future availability, research efforts need to be increased today, including clinical trials. Initial results of the first efficacy trials will be available in the next 2-3 years, and it is important to start planning how new vaccines should be used if found to be effective. Calls for the development of financial mechanisms as an incentive to industry and to ensure equitable distribution of vaccines in less-developed countries. (Original abstract - amended)</description><identifier>ISSN: 0140-6736</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><subject>Development ; Human immunodeficiency virus ; Vaccines</subject><ispartof>The Lancet (British edition), 2000-06, Vol.10, p.2061-2066</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,30999,64386</link.rule.ids></links><search><creatorcontrib>Esparza, J</creatorcontrib><creatorcontrib>Bhamarapravati, N</creatorcontrib><title>Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?</title><title>The Lancet (British edition)</title><description>Argues that an HIV-1 vaccine offers the best long-term hope to control the AIDS pandemic, especially in less-developed countries, and that to ensure its future availability, research efforts need to be increased today, including clinical trials. Initial results of the first efficacy trials will be available in the next 2-3 years, and it is important to start planning how new vaccines should be used if found to be effective. Calls for the development of financial mechanisms as an incentive to industry and to ensure equitable distribution of vaccines in less-developed countries. (Original abstract - amended)</description><subject>Development</subject><subject>Human immunodeficiency virus</subject><subject>Vaccines</subject><issn>0140-6736</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNqNjrsOgjAYRjtoIl7e4Z-cICnhpi7GGA3uxpUU-JGa0mJbILy9xPgALudbzpecGXGoH1IvToJ4QZbGvCilYUwjh-SnokCBmlkun2BrhBJ7FKptUFpgsoSqs51GYD3jguVccDuCqiC9PTwfelYUXKI5wFCP7gSUX2p0v-daDcc1mVdMGNz8dkW218v9nHqtVu8Ojc0abqYIwSSqzmRRsqP72I-Cv8UPTkZHBQ</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>Esparza, J</creator><creator>Bhamarapravati, N</creator><scope>7QJ</scope></search><sort><creationdate>20000601</creationdate><title>Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?</title><author>Esparza, J ; Bhamarapravati, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_578096153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Development</topic><topic>Human immunodeficiency virus</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Esparza, J</creatorcontrib><creatorcontrib>Bhamarapravati, N</creatorcontrib><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Esparza, J</au><au>Bhamarapravati, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?</atitle><jtitle>The Lancet (British edition)</jtitle><date>2000-06-01</date><risdate>2000</risdate><volume>10</volume><spage>2061</spage><epage>2066</epage><pages>2061-2066</pages><issn>0140-6736</issn><coden>LANCAO</coden><abstract>Argues that an HIV-1 vaccine offers the best long-term hope to control the AIDS pandemic, especially in less-developed countries, and that to ensure its future availability, research efforts need to be increased today, including clinical trials. Initial results of the first efficacy trials will be available in the next 2-3 years, and it is important to start planning how new vaccines should be used if found to be effective. Calls for the development of financial mechanisms as an incentive to industry and to ensure equitable distribution of vaccines in less-developed countries. (Original abstract - amended)</abstract></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2000-06, Vol.10, p.2061-2066
issn 0140-6736
language eng
recordid cdi_proquest_miscellaneous_57809615
source Business Source Complete; Applied Social Sciences Index & Abstracts (ASSIA); ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland
subjects Development
Human immunodeficiency virus
Vaccines
title Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T03%3A49%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accelerating%20the%20development%20and%20future%20availability%20of%20HIV-1%20vaccines:%20why,%20when,%20where,%20and%20how?&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Esparza,%20J&rft.date=2000-06-01&rft.volume=10&rft.spage=2061&rft.epage=2066&rft.pages=2061-2066&rft.issn=0140-6736&rft.coden=LANCAO&rft_id=info:doi/&rft_dat=%3Cproquest%3E57809615%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=57809615&rft_id=info:pmid/&rfr_iscdi=true